Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
IMCR
#2114
Immunocore Holdings plc - American Depositary Shares
33.4
8
USD
+0.03%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+3.05%
Monthly Change
+15.61%
6 month change
+1.03%
Year Change
0.00%
Previous Close
32.4
9
Open
33.6
2
Low
33.2
1
High
33.7
8
Volume
473
Markets
US Stock Market
Healthcare
Biotechnology
IMCR
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
31.78 M
43.86 M
48.09 M
49.82 M
50.07 M
50.7 M
50.87 M
Valuation ratios
Enterprise value
—
1.5 B
2.67 B
3.17 B
1.41 B
1.69 B
1.66 B
Price to earnings ratio
—
—
—
-63.4
-28.92
-48.89
-60.32
Price to sales ratio
—
—
—
14.04
4.75
4.37
4.17
Price to cash flow ratio
—
—
—
1 191.29
56.59
-163.13
-70.23
Price to book ratio
—
—
—
9.5
4.09
4.59
1.1
Enterprise value to EBITDA ratio
—
—
—
-57.15
-21.31
-39.88
-53.36
Profitability ratios
Return on assets %
—
—
—
-0.09
-0.05
-0.03
0.01
Return on equity %
—
—
—
-0.15
-0.14
-0.09
0.03
Return on invested capital %
—
—
—
-126.09
-131.84
-126.65
10.73
Gross margin %
—
—
—
99.58
99.12
98.73
99.59
Operating margin %
—
—
—
-23.91
-22.71
-11.34
6.82
EBITDA margin %
—
—
—
-22.27
-21.36
-10.56
7.71
Net margin %
—
—
—
-22.17
-16.47
-8.88
12.16
Liquidity ratios
Quick ratio
—
—
—
3.77
4.36
4.01
4.15
Current ratio
—
—
—
3.8
4.38
4.04
4.18
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
—
—
0.42
0.39
0.37
0.1
Solvency ratios
Debt to assets ratio
—
—
—
0.08
0.39
0.37
0.37
Debt to equity ratio
—
—
—
0.13
1.08
1.03
1
Long term debt to total assets ratio
—
—
—
0.17
0.39
0.37
0.37
Long term debt to total equity ratio
—
—
—
0.27
1.08
1.03
1
Per share metrics
Operating cash flow per share
—
—
—
0.06
0.52
-0.21
-0.48
EBIT per share
—
—
—
-1.22
-1.41
-0.9
-0.69
EBITDA per share
—
—
—
-1.14
-1.33
-0.84
-0.63
Total debt per share
—
—
—
0.98
7.82
7.81
7.44
Cash per share
—
—
—
9.05
16.41
17.16
15.96
Net current asset value per share
—
—
—
10.82
18.6
19.8
18.96
Tangible book value per share
—
—
—
7.54
7.22
7.57
7.44
Working capital per share
—
—
—
7.97
14.36
14.9
14.43
Book value per share
—
—
—
7.54
7.22
7.57
7.44
News
EU Approves Expanded Use of ABBV's Tepkinly in Follicular Lymphoma
AtaiBeckley Completes VLS-01 Dosing in Phase IIb Depression Study
TG Therapeutics Begins Phase II Study With Briumvi in Schizophrenia
Novartis to Expand Oncology Pipeline With Myricx Bio Acquisition
Reasons Why Investors Should Consider Betting on Neurocrine Stock
UTHR Strengthens Regenerative Medicine Platform With Thymmune Deal
NVS Gains EC Approval for SMA Therapy Itvisma in Broad Population
Vertex Gets FDA Nod for Expanded Use of Casgevy in SCD & TDT
CPRX's Agamree Shows Potential Beyond DMD After Positive Phase I Data
PCRX's Exparel Wins Separate Reimbursement From UnitedHealthcare
Collegium Pharmaceutical Stock Gains 12% in Three Months: Here's Why
VRDN Stock Rises 6.3% in a Week: Here's What You Need to Know